Search for: "Ranbaxy Pharmaceuticals Inc" Results 1 - 20 of 101
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2010, 9:59 pm by Patent Docs
By James DeGiulio -- Medicis Settles Solodyn Infringement Case with Ranbaxy Medicis Pharmaceutical Corp. has reached consent and licensing agreements with Ranbaxy Laboratories Inc., thus settling patent infringement claims against Ranbaxy over Medicis' oral acne drug Solodyn. [read post]
8 Aug 2010, 8:32 pm by Patent Docs
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS… [read post]
31 Jul 2020, 4:00 pm by Pete Strom
Pharmaceutical Manufacturer that Makes Generic Lipitor Will Pay Millions for Dangerous Drugs A subsidiary of India’s largest pharmaceutical company, Ranbaxy USA Inc, has agreed to pay the United States federal government a record $500 million in criminal and civil fines for selling adulterated drugs, including the generic version of Lipitor, and lying to regulators during the year-long investigation. [read post]
21 May 2013, 2:26 pm by Fraud Fighters
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
14 Jun 2009, 8:17 pm
Ranbaxy Inc. et al. 1:09-cv-00435; filed June 11, 2009 in the District Court of Delaware Infringement of U.S. [read post]
25 Nov 2012, 8:36 pm
A generic form of the cholesterol lowering drug Lipitor is now being recalled by India-based Ranbaxy Pharmaceuticals Inc. because small glass particles may be in select batches. [read post]
19 Aug 2007, 5:13 pm
Ranbaxy Inc. et al.3:07-cv-03755; filed August 9, 2007 in the District of Court... [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
30 Sep 2013, 8:12 am by Gene Quinn
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
25 Mar 2008, 9:57 am by GenericIPguy
I am not sure about the products as yet.Case details: Plaintiffs: Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC and Warner-Lambert Export [read post]
3 May 2011, 7:16 am by Zoe Tillman
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]